Immuneering Corp’s recently made public that its CHIEF SCIENTIFIC OFFICER Hall Brett Matthew acquired Company’s shares for reported $20020.0 on Jun 20 ’25. In the deal valued at $2.70 per share,7,415 shares were bought. As a result of this transaction, Hall Brett Matthew now holds 353,311 shares worth roughly $1.25 million.
Then, Hall Brett Matthew bought 6,007 shares, generating $14,596 in total proceeds. Upon buying the shares at $2.43, the CHIEF SCIENTIFIC OFFICER now owns 359,318 shares.
Before that, Brakewood Harold Eugene bought 1,900 shares. Immuneering Corp shares valued at $4,804 were divested by the Chief Business Officer at a price of $2.53 per share. As a result of the transaction, Brakewood Harold Eugene now holds 5,800 shares, worth roughly $20474.0.
Morgan Stanley downgraded its Immuneering Corp [IMRX] rating to an Underweight from a an Equal-weight in a research note published recently. A number of analysts have revised their coverage, including Needham’s analysts, who remained covering the stock and in mid March has reiterated a ‘”a Buy”‘ rating for it. TD Cowen also remained covering IMRX and has decreased its forecast on March 15, 2024 with a “Market perform” recommendation from previously “an Outperform” rating. Jefferies revised its rating on March 15, 2024. It rated IMRX as “a Hold” which previously was an “a Buy”.
Price Performance Review of IMRX
On Friday, Immuneering Corp [NASDAQ:IMRX] saw its stock jump 10.66% to $3.53. Over the last five days, the stock has gained 37.89%. Immuneering Corp shares have risen nearly 146.85% since the year began. Nevertheless, the stocks have risen 60.45% over the past one year. While a 52-week high of $3.83 was reached on 06/27/25, a 52-week low of $1.00 was recorded on 05/12/25.
Levels Of Support And Resistance For IMRX Stock
The 24-hour chart illustrates a support level at 3.16, which if violated will result in even more drops to 2.78. On the upside, there is a resistance level at 3.89. A further resistance level may holdings at 4.25.
How much short interest is there in Immuneering Corp?
A steep rise in short interest was recorded in Immuneering Corp stocks on 2025-06-13, growing by 0.23 million shares to a total of 0.89 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 0.66 million shares. There was a rise of 26.07%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 01, 2023 when Needham began covering the stock and recommended ‘”a Buy”‘ rating along with a $20 price target.
